Location: Home > Pharma China Web Edition
  • search
  • go
  • Industry News
  • 10/15/2024China Expands Health Silk Road to Dominate Africa's Pharmaceutical Mar...
  • 10/15/2024Eli Lilly Invests $200M to Expand Chinese Manufacturing Facility for D...
  • 10/15/2024Akeso Secures $250M to Propel Global Expansion of Its Innovative Drug...
  • 10/15/2024Wuhan iRegene Completes Over CNY 100M Series B Financing
  • 10/15/2024AstraZeneca/Daiichi's Enhertu Approved in China as First HER2-directed...
  • 10/11/2024CanSino Receives Over $17M from Gates Foundation to Accelerate Polio V...
  • 10/11/2024Japan Strengthens Pharmaceutical Supply Chain to Reduce Dependence on ...
  • 10/11/2024InnoCare Announces Phase II Study Results of TYK2 Inhibitor ICP-488 Me...
  • 10/10/2024Bio-Thera Secures $110M Drug Licensing Deal with Hungary's Gedeon Rich...
  • 10/10/2024Guangdong Aims to Boost Biopharma Sector to Over CNY 1 Trillion by 202...
  • 10/10/2024Eli Lilly Submits Chinese NDA for Its Anti-IL23 Antibody Mirikizumab
  • 10/10/2024Nona Biosciences Enters Strategic Collaboration with OverT Bio to Adva...
  • 10/10/2024QuantumPharma's Subsidiary Ailux Biologics Partners with Janssen Biote...
  • 10/9/2024US Venture Capital Opens Funding Opportunities for China Biotech Firms
  • 10/9/2024Bayer Launches Life Sciences Incubator in Shanghai
  • 10/8/2024China Grants Conditional Approval to Biogen's ALS Therapy Qalsody
  • 10/8/2024AstraZeneca Expanding R&D pipeline in China
  • 10/8/2024CSPC Announces Regulatory Milestones in China and the U.S.
  • 10/8/2024BeiGene Launches Tevimbra in US, Enters Competitive PD-1 Inhibitor Mar...
  • 10/8/2024Wuhan YZY Biopharma and CT Tianqing Enter Exclusive License Agreement ...
  • 10/8/2024Wuhan YZY Biopharma and CT Tianqing Enter Exclusive License Agreement ...
  • 10/8/2024Zephyrm Bioscience Files for IPO on HKSE with CICC as Sponsor
  • 10/8/2024Genor Biopharma to Merge with Eddingpharm in Strategic Reverse Takeove...
  • 10/8/2024Innovent and Ask Pharm Enter Strategic Deal for Limertinib 
  • 10/8/2024AstraZeneca gains rights to CSPC's lipid-lowering therapy in deal wort...
  • 10/8/2024MediLink and Amgen Enter Global Clinical Trial Deal on YL201 Combinat...
  • 10/3/2024Domestic Pharma Companies Saw Rapid Growth in Outlicensing Deals in 20...
  • 10/3/2024WuXi Considers Asset Sales Amid BIOSECURE Scrutiny: FT
  • 10/1/2024AFT in China License Deal with Xizang Weixinkang Pharma for Maxigesic ...
  • 10/1/2024Haleon Plans to Raise Stake in Chinese JV to 88%
  • Page:17/23 Total number of articles:663: [First][<<] [15] [16] [17] [18] [19] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group